Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» solid tumors
solid tumors
Moderna reveals Claudin18.2 ambitions via cancer vaccine, solid tumor CAR-T combo plans
Fierce Biotech
Mon, 08/21/23 - 10:05 am
Moderna Therapeutics
Claudin18.2
MRNA
vaccines
CAR-T
cancer vaccine
solid tumors
Bio-Thera reports positive data from solid tumors therapy trial
Clinical Trials Arena
Mon, 08/14/23 - 10:11 am
Bio-Thera Solutions
solid tumors
clinical trials
BAT8006
FDA clears Qualigen’s IND for trial of solid tumour therapy
Clinical Trials Arena
Wed, 08/2/23 - 10:20 am
Qualigen Therapeutics
clinical trials
solid tumors
QN-302
Enhertu offers survival benefits in Phase II solid tumour trial
Clinical Trials Arena
Sat, 07/29/23 - 10:42 pm
AstraZeneca
Daiichi Sankyo
Enhertu
clinical trials
solid tumors
Roche Decides Not to Exercise Solid Tumor Option with SQZ
BioSpace
Tue, 07/25/23 - 08:51 pm
Roche
solid tumors
SQZ Biotech
Rain Oncology to cut 65% of staff after milademetan Phase 3 trial failure
Medical Marketing and Media
Wed, 05/31/23 - 11:00 am
Rain Oncology
layoffs
clinical trials
milademetan
oncology
solid tumors
Xilio reports preliminary data from Phase I solid tumors therapy trial
Clinical Trials Arena
Tue, 05/30/23 - 09:40 am
Xilio Therapeutics
clinical trials
solid tumors
XTX101
UCB partners with Ariceum for treatment of immune-related diseases and cancer
Biopharma Reporter
Fri, 05/12/23 - 11:30 am
UCB Pharma
Ariceum
R&D
radiopharmaceuticals
solid tumors
Novartis Culls 10% of Pipeline, Doubles Down on Five Core Therapeutic Areas
BioSpace
Wed, 04/26/23 - 10:24 am
Novartis
earnings
solid tumors
hematology
immunology
Neuroscience
cardiovascular disease
Roche, seeing MAGE magic wane, makes pair of solid tumor bispecifics disappear
Fierce Biotech
Wed, 04/26/23 - 10:08 am
Roche
earnings
solid tumors
MAGE-A4
FDA clears Sensei’s IND to start Phase I/II therapy trial of SNS-101
Clinical Trials Arena
Fri, 04/21/23 - 10:04 am
Sensei Biotherapeutics
SNS-101
clinical trials
solid tumors
BMS signs ADC development deal with Munich-based biotech worth more than $1B
Medical Marketing and Media
Thu, 04/20/23 - 12:00 pm
Bristol Myers Squibb
Tubulius
cancer
solid tumors
antibody-drug conjugate
In a refreshingly transparent disclosure, NGM Bio CEO reveals what led to 33% head count reduction
Fierce Biotech
Wed, 04/5/23 - 11:58 am
NGM Biopharmaceuticals
solid tumors
layoffs
BioNTech Adds Two ADCs in Second Deal in as Many Months
BioSpace
Mon, 04/3/23 - 10:44 pm
BioNTech
antibody-drug conjugate
solid tumors
Duality Biologics
Positive topline data for Bolt’s BDC-1001 in HER2 solid tumours
Clinical Trials Arena
Fri, 03/31/23 - 10:22 am
Bolt Biotherapeutics
BDC-1001
solid tumors
Roche
Bristol Myers Squibb
FDA grants full approval to Keytruda in tumor-agnostic setting
Endpoints
Thu, 03/30/23 - 10:59 pm
Merck
Keytruda
tumor agnostic
solid tumors
With one of biotech's largest private rounds in a year, ArriVent enters PhIII
Endpoints
Mon, 03/27/23 - 11:25 am
ArriVent Biopharma
funding
solid tumors
23andMe doses first patient in ph2a anti-tumour monotherapy
Pharmaphorum
Wed, 03/1/23 - 09:48 am
23andMe
clinical trials
solid tumors
23ME-00610
Months after going public, Apexigen lays of 55% of staff and considers exit routes
Fierce Biotech
Mon, 02/27/23 - 10:05 am
Apexigen
Epitomics
layoffs
solid tumors
sotigalimab
FDA hands down a partial hold for PhI/II trial of Blueprint’s CDK2 inhibitor
Endpoints
Fri, 02/10/23 - 11:05 am
FDA
Blueprint Medicine
clinical trials
solid tumors
BLU-222
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »